259 related articles for article (PubMed ID: 15927846)
21. Inhibitory effect of genistein on mouse colon cancer MC-26 cells involved TGF-beta1/Smad pathway.
Yu Z; Tang Y; Hu D; Li J
Biochem Biophys Res Commun; 2005 Aug; 333(3):827-32. PubMed ID: 15963949
[TBL] [Abstract][Full Text] [Related]
22. Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells.
Tsunobuchi H; Ishisaki A; Imamura T
Biochem Biophys Res Commun; 2004 Apr; 316(3):712-9. PubMed ID: 15033458
[TBL] [Abstract][Full Text] [Related]
23. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
24. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
25. SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke.
Springer J; Scholz FR; Peiser C; Groneberg DA; Fischer A
Biol Chem; 2004 Jul; 385(7):649-53. PubMed ID: 15318814
[TBL] [Abstract][Full Text] [Related]
26. Expression of TGF-beta signaling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells.
Xu G; Chakraborty C; Lala PK
Biochem Biophys Res Commun; 2001 Sep; 287(1):47-55. PubMed ID: 11549251
[TBL] [Abstract][Full Text] [Related]
27. Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells.
Ye L; Zhang H; Zhang L; Yang G; Ke Q; Guo H; Bu H
Int J Oncol; 2006 Nov; 29(5):1149-57. PubMed ID: 17016646
[TBL] [Abstract][Full Text] [Related]
28. Signaling "cross-talk" between TGF-beta1 and ECM signals in chondrocytic cells.
Schneiderbauer MM; Dutton CM; Scully SP
Cell Signal; 2004 Oct; 16(10):1133-40. PubMed ID: 15240008
[TBL] [Abstract][Full Text] [Related]
29. Intracellular dynamics of Smad-mediated TGFbeta signaling.
Greene RM; Nugent P; Mukhopadhyay P; Warner DR; Pisano MM
J Cell Physiol; 2003 Nov; 197(2):261-71. PubMed ID: 14502566
[TBL] [Abstract][Full Text] [Related]
30. TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses.
Johnsen SA; Subramaniam M; Janknecht R; Spelsberg TC
Oncogene; 2002 Aug; 21(37):5783-90. PubMed ID: 12173049
[TBL] [Abstract][Full Text] [Related]
31. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
Halder SK; Beauchamp RD; Datta PK
Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta1 expression in EL4 lymphoma cells overexpressing growth hormone.
Farmer JT; Weigent DA
Cell Immunol; 2006 Mar; 240(1):22-30. PubMed ID: 16839530
[TBL] [Abstract][Full Text] [Related]
33. Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.
Inamoto S; Iwata S; Inamoto T; Nomura S; Sasaki T; Urasaki Y; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
Oncogene; 2007 Feb; 26(6):893-904. PubMed ID: 16909115
[TBL] [Abstract][Full Text] [Related]
34. Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.
Weinstein M; Monga SP; Liu Y; Brodie SG; Tang Y; Li C; Mishra L; Deng CX
Mol Cell Biol; 2001 Aug; 21(15):5122-31. PubMed ID: 11438667
[TBL] [Abstract][Full Text] [Related]
35. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
[TBL] [Abstract][Full Text] [Related]
36. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
Fukuda M; Kurosaki H; Sairenji T
J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
[TBL] [Abstract][Full Text] [Related]
37. [The roles of Smad 2/3 in transforming growth factor-beta 1 signaling in human dental pulp cells].
Bao LY; Niu ZY; Wang P
Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):39-42. PubMed ID: 12760775
[TBL] [Abstract][Full Text] [Related]
38. Involvement of Smads in TGFbeta1-induced furin (fur) transcription.
Blanchette F; Rudd P; Grondin F; Attisano L; Dubois CM
J Cell Physiol; 2001 Aug; 188(2):264-73. PubMed ID: 11424093
[TBL] [Abstract][Full Text] [Related]
39. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway.
Watanabe Y; Kinoshita A; Yamada T; Ohta T; Kishino T; Matsumoto N; Ishikawa M; Niikawa N; Yoshiura K
J Hum Genet; 2002; 47(9):478-83. PubMed ID: 12202987
[TBL] [Abstract][Full Text] [Related]
40. Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model.
Kuga H; Morisaki T; Nakamura K; Onishi H; Noshiro H; Uchiyama A; Tanaka M; Katano M
Oncogene; 2003 Oct; 22(49):7838-47. PubMed ID: 14586410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
